SCHEMBL6814636

SCHEMBL6814636

N#Cc1ccc(NC(=O)c2ccco2)c(C(=O)O)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.57
KMT2A Q03164 3/20 0.57
MEN1 O00255 2/20 0.57
MAPT P10636 2/20 0.57
GAA P10253 2/20 0.57
CYP2C19 P33261 2/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C9 P11712 1/20 0.52
MAPK1 P28482 2/20 0.49
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 2/20 0.49
LMNA P02545 1/20 0.49
HSD17B10 Q99714 1/20 0.49
PKM P14618 1/20 0.49
GFER P55789 1/20 0.49
ALB P02768 1/20 0.48
GALR3 O60755 1/20 0.48
TSHR P16473 1/20 0.48
RAB9A P51151 1/20 0.48
HDAC1 Q13547 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6822318 0.82 MAPT (0.48) CYP1A2KMT2AMEN1MAPTGAA
SCHEMBL14075179 0.80 LTC4S (0.66) CYP1A2KMT2AGAACYP2C19CYP3A4
SCHEMBL6815137 0.80 GFER (0.71) CYP1A2KMT2AMEN1MAPTGAA
SCHEMBL6933566 0.80 CYP1A2 (0.61) CYP1A2KMT2AMEN1MAPTGAA
SCHEMBL21701478 0.80 CYP1A2 (0.61) CYP1A2KMT2AMEN1MAPTGAA
SCHEMBL6353963 0.80 KMT2A (0.62) KMT2AMEN1MAPTALDH1A1PKM
SCHEMBL6924687 0.78 GALK1 (0.57) KMT2AMEN1PKMRAB9AHDAC1
SCHEMBL6359401 0.78 ALB (0.63) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL6818185 0.78 HTT (0.45) CYP1A2KMT2AMEN1MAPTGAA
SCHEMBL15528812 0.78 MAPK1 (0.71) CYP1A2KMT2AMEN1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed
WO-2004018428-A1 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 CYP1A2 710/4885KMT2A 2853/4885MEN1 4132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.